Cargando…
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
Ataxia-telangiectasia mutated (ATM) plays a central role in the cellular response to DNA damage and ATM alterations are common in several tumor types including bladder cancer. However, the specific impact of ATM alterations on therapy response in bladder cancer is uncertain. Here, we combine preclin...
Autores principales: | Zhou, Yuzhen, Börcsök, Judit, Adib, Elio, Kamran, Sophia C., Neil, Alexander J., Stawiski, Konrad, Freeman, Dory, Stormoen, Dag Rune, Sztupinszki, Zsofia, Samant, Amruta, Nassar, Amin, Bekele, Raie T., Hanlon, Timothy, Valentine, Henkel, Epstein, Ilana, Sharma, Bijaya, Felt, Kristen, Abbosh, Philip, Wu, Chin-Lee, Efstathiou, Jason A., Miyamoto, David T., Anderson, William, Szallasi, Zoltan, Mouw, Kent W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664985/ https://www.ncbi.nlm.nih.gov/pubmed/37992168 http://dx.doi.org/10.1126/sciadv.adg2263 |
Ejemplares similares
-
PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
por: Dillon, Kasia M., et al.
Publicado: (2022) -
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
por: Prosz, Aurel, et al.
Publicado: (2023) -
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
por: Prosz, Aurel, et al.
Publicado: (2023) -
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
por: Diossy, Miklos, et al.
Publicado: (2021) -
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
por: Miao, Chenkui, et al.
Publicado: (2022)